Position in LLY
as of Jun 30, 2026
· filed Jul 1, 2026
Position Value
$397,011
+$47,499 QoQ
Shares Held
331
-12.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#3,943
of 4,605 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Global Wealth Strategies & Associates holds $1,240,903 across 3 Drug Manufacturers - General names. LLY ranks #2 (32.0% of the industry book) .
All Filings in LLY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $397,011 | 331 | Shares | Sole | 2026-07-01 | |
| 2026-03-31 | $349,512 | 380 | Shares | Sole | 2026-04-03 | |
| 2025-12-31 | $427,722 | 398 | Shares | Sole | 2026-01-02 | |
| 2025-09-30 | $260,946 | 342 | Shares | Sole | 2025-10-02 | |
| 2025-06-30 | $289,985 | 372 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $332,841 | 403 | Shares | Sole | 2025-04-02 | |
| 2024-12-31 | $448,532 | 581 | Shares | Sole | 2025-01-02 | |
| 2024-09-30 | $519,160 | 586 | Shares | Sole | 2024-10-01 | |
| 2024-06-30 | $567,673 | 627 | Shares | Sole | 2024-07-02 | |
| 2024-03-31 | $476,889 | 613 | Shares | Sole | 2024-04-01 | |
| 2023-12-31 | $366,073 | 628 | Shares | Sole | 2024-01-02 | |
| 2023-09-30 | $345,374 | 643 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $310,933 | 663 | Shares | Sole | 2023-07-05 | |
| 2023-03-31 | $227,687 | 663 | Shares | Sole | 2023-04-03 | |
| 2022-12-31 | $242,551 | 663 | Shares | Sole | 2023-01-17 | |
| No filing history on record for this holder in this stock. | ||||||